DENALI Trademark

Trademark Overview

On Wednesday, May 24, 2017, a trademark application was filed for DENALI with the United States Patent and Trademark Office. The USPTO has given the DENALI trademark a serial number of 87463175. The federal status of this trademark filing is REGISTERED as of Tuesday, January 12, 2021. This trademark is owned by Denali Therapeutics Inc.. The DENALI trademark is filed in the Pharmaceutical Products category with the following description:

pharmaceutical preparations for diagnosing and treating neurodegenerative diseases
denali

General Information

Serial Number87463175
Word MarkDENALI
Filing DateWednesday, May 24, 2017
Status700 - REGISTERED
Status DateTuesday, January 12, 2021
Registration Number6245726
Registration DateTuesday, January 12, 2021
Mark Drawing5 - Drawing with word(s) / letter(s) / number(s) in Stylized form
Published for Opposition DateTuesday, October 3, 2017

Trademark Statements

Description of MarkThe mark consists of the word "DENALI" in stylized format.
Goods and Servicespharmaceutical preparations for diagnosing and treating neurodegenerative diseases
Indication of Colors claimedColor is not claimed as a feature of the mark.

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, June 1, 2017
Primary Code005
First Use Anywhere DateMonday, November 9, 2020
First Use In Commerce DateMonday, November 9, 2020

Trademark Owner History

Party NameDenali Therapeutics Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressSouth San Francisco, CA 94080
Party NameDenali Therapeutics Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSouth San Francisco, CA 94080
Party NameDenali Therapeutics Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSouth San Francisco, CA 94080

Trademark Events

Event DateEvent Description
Tuesday, October 3, 2017OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Saturday, May 27, 2017NEW APPLICATION ENTERED
Thursday, June 1, 2017NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, August 23, 2017ASSIGNED TO EXAMINER
Wednesday, August 23, 2017APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, September 13, 2017NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, October 3, 2017PUBLISHED FOR OPPOSITION
Wednesday, May 8, 2019SOU TEAS EXTENSION RECEIVED
Tuesday, November 28, 2017NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Sunday, May 20, 2018SOU TEAS EXTENSION RECEIVED
Sunday, May 20, 2018SOU EXTENSION 1 FILED
Sunday, May 20, 2018SOU EXTENSION 1 GRANTED
Tuesday, May 22, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, November 16, 2018SOU TEAS EXTENSION RECEIVED
Friday, November 16, 2018SOU EXTENSION 2 FILED
Friday, November 16, 2018SOU EXTENSION 2 GRANTED
Tuesday, November 20, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, August 20, 2019TEAS CHANGE OF OWNER ADDRESS RECEIVED
Wednesday, November 27, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, May 8, 2019SOU EXTENSION 3 FILED
Wednesday, May 8, 2019SOU EXTENSION 3 GRANTED
Friday, May 10, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, August 20, 2019APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Monday, November 25, 2019SOU TEAS EXTENSION RECEIVED
Monday, November 25, 2019SOU EXTENSION 4 FILED
Monday, November 25, 2019SOU EXTENSION 4 GRANTED
Tuesday, May 12, 2020SOU TEAS EXTENSION RECEIVED
Thursday, November 19, 2020TEAS STATEMENT OF USE RECEIVED
Tuesday, May 12, 2020SOU EXTENSION 5 FILED
Wednesday, May 27, 2020CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, May 27, 2020SOU EXTENSION 5 GRANTED
Thursday, May 28, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, November 19, 2020USE AMENDMENT FILED
Friday, November 20, 2020STATEMENT OF USE PROCESSING COMPLETE
Tuesday, December 8, 2020ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Wednesday, December 9, 2020NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, January 12, 2021REGISTERED-PRINCIPAL REGISTER
Tuesday, February 4, 2025TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, February 4, 2025ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, February 4, 2025TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

Related Keywords

denali neurodegenerative diseases treating diagnosing preparations pharmaceutical